Testing Or Monitoring Pacer Function Patents (Class 607/27)
-
Publication number: 20100280567Abstract: A method and apparatus for automatically identifying various types of cardiac and non-cardiac oversensing and automatically performing a corrective action to reduce the likelihood of oversensing is provided. EGM data, including time intervals between sensed and paced events and signal morphologies, are analyzed for patterns indicative of various types of oversensing, including oversensing of far-field R-waves, R-waves, T-waves, or noise associated with electromagnetic interference, non-cardiac myopotentials, a lead fracture, or a poor lead connection. Identification of oversensing and its suspected cause are reported so that corrective action may be taken. The corrective action may include, for example, adjusting sensing parameters such as blanking periods, decay constants, decay delays, threshold values, sensitivity values, electrode configurations and the like.Type: ApplicationFiled: July 13, 2010Publication date: November 4, 2010Inventor: Bruce D. Gunderson
-
Patent number: 7822473Abstract: A method and system for setting the operating parameters of a cardiac rhythm management device in which a plurality of parameter optimization algorithms are available. A measured feature of an electrophysiological signal such as QRS width has been shown to be useful in selecting among certain parameter optimization algorithms. In one embodiment, one or more resynchronization pacing parameters are set based on one or both of the feature extracted from an electrogram signal and the value of a resynchronization pacing parameter which tends to minimize the intrinsic atrial rate.Type: GrantFiled: February 19, 2007Date of Patent: October 26, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Andrew P. Kramer, Veerichetty Kadhiresan, Jiang Ding, Lawrence Baumann, Scott Vanderlinde
-
Method and apparatus for reducing far-field interchamber interference in an implanted medical device
Patent number: 7822475Abstract: An implantable medical device comprises at least two sensing channels for receiving sensed first and second location electrical signals originating from two different locations of a heart. A control unit is connected to the sensing channels and is adapted to process sensed electrical signals originating from first and second locations of the heart. The control unit incorporates an adaptive filter compensator adapted to generate an estimate signal for compensating a far-field contribution of the second location signal to the first location signal, thereby generating an output signal representing a near field signal originating from the first location. A gate is connected to the second location sensing channel and is adapted to enable the adaptive filter compensator only if a predetermined signal is sensed via the second location sensing channel.Type: GrantFiled: December 17, 2004Date of Patent: October 26, 2010Assignee: Biotronik CRM Patent AGInventors: Richard A. Schomburg, Christopher S. de Voir, Dirk Muessig -
Patent number: 7818059Abstract: Embodiments of the invention provide systems and methods for an implantable medical device comprising means for selecting between an atrial chamber reset (ACR) test and an atrioventricular conduction (AVC) test to provide atrial capture management and means for switching between an atrial-based pacing mode and a dual chamber pacing mode based on detecting relatively reliable atrioventricular conduction.Type: GrantFiled: April 27, 2005Date of Patent: October 19, 2010Assignee: Medtronic, Inc.Inventors: John C. Rueter, Todd J. Sheldon
-
Patent number: 7801612Abstract: A system and method for managing locally-initiated medical device interrogation is presented. A noncontinuously coupleable interface is provided over which to retrieve patient data recorded and transiently staged by a medical device monitoring physiological measures of a patient. The patient data is periodically retrieved by interfacing to and interrogating the medical device per a pre-defined schedule defining autonomous patient data retrieval frequency. Further retrieval of the patient data is permitted independent of the pre-defined schedule by enabling operation of the interface based on a remotely-specifiable criteria for controlling locally-initiated patient data retrieval.Type: GrantFiled: June 5, 2006Date of Patent: September 21, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: David C. Johnson, Howard D. Simms, Kenneth P. Hoyme, Muralidharan Srivathsa, Benjamin L. Somberg
-
Patent number: 7801610Abstract: Methods and systems for classifying cardiac responses to pacing stimulation and managing retrograde conduction and pacemaker mediated tachyarrhythmia are described. An atrial pacing pulse and a ventricular pacing pulse are delivered during a paced cardiac cycle. A post ventricular atrial refractory period (PVARP) is timed following the ventricular pacing pulse. The system determines if the atrial pacing pulse captures the atrium. An atrial depolarization occurring after the paced cardiac cycle is sensed. Retrograde management is initiated if the atrial pacing pulse did not capture the atrium and the atrial depolarization occurred during the PVARP. Pacemaker mediated tachyarrhythmia (PMT) is initiated if the atrial pacing pulse did not capture the atrium and the atrial depolarization did not occur during the PVARP.Type: GrantFiled: November 17, 2006Date of Patent: September 21, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Derek D. Bohn, Ankur Garg, Eric K. Enrooth
-
Patent number: 7797047Abstract: An implantable medical device (IMD) includes a lead status monitoring system. The lead status monitoring system employs a method including the steps of: collecting data sets from a lead impedance source, a stimulation threshold source, and at least one additional source included in the IMD; and processing the data sets to determine if a lead status event has occurred.Type: GrantFiled: February 18, 2004Date of Patent: September 14, 2010Assignee: Medtronic, Inc.Inventors: David J. Jorgenson, Ross O. Starkson, Rick D. McVenes, Charles D. Trautmann, John D. Wahlstrand, Bradley C. Peck
-
Patent number: 7792585Abstract: Methods and systems are provided for expediting set-up of a multi-electrode lead (MEL). In accordance with specific embodiments, such an MEL includes N groups of electrodes, with each of the N groups including at least M electrodes, where N?2 and M is ?2. Electrodes in a same group are within 5 mm of one another. Electrodes in separate groups are at least 10 mm from one another. Specific embodiments relate to methods for identifying cathode-anode electrode configurations that can be used to not exceed a maximum acceptable capture threshold, and that provide a sensed intrinsic R-wave amplitude of at least a minimum acceptable sensing threshold. Such thresholds can be default values, or can be defined by a user (e.g., clinician, physician, nurse, or the like).Type: GrantFiled: May 17, 2007Date of Patent: September 7, 2010Assignee: PaceSetter, Inc.Inventor: Anne M. Shelchuk
-
Patent number: 7783364Abstract: Systems and methods are provided for graphically configuring leads for a medical device. According to one aspect, the system generally comprises a medical device and a processing device, such as a programmer or computer, adapted to be in communication with the medical device. The medical device has at least one lead with at least one electrode in a configuration that can be changed using the processing device. The processing device provides a graphical display of the configuration, including a representative image of a proposed electrical signal to be applied by the medical device between the at least one electrode of the medical device and at least one other electrode before the medical device applies the electrical signal between the at least one electrode and the at least one other electrode. In one embodiment, the graphical display graphically represents the lead(s), the electrode(s), a pulse polarity, and a vector.Type: GrantFiled: May 17, 2007Date of Patent: August 24, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Par Lindh, James Kalgren, Rene H. Wentkowski, John Lockhart
-
Patent number: 7783354Abstract: A method and apparatus for automatically identifying various types of cardiac and non-cardiac oversensing and automatically performing a corrective action to reduce the likelihood of oversensing is provided. EGM data, including time intervals between sensed and paced events and signal morphologies, are analyzed for patterns indicative of various types of oversensing, including oversensing of far-field R-waves, R-waves, T-waves, or noise associated with electromagnetic interference, non-cardiac myopotentials, a lead fracture, or a poor lead connection. Identification of oversensing and its suspected cause are reported so that corrective action may be taken. The corrective action may include, for example, adjusting sensing parameters such as blanking periods, decay constants, decay delays, threshold values, sensitivity values, electrode configurations and the like.Type: GrantFiled: April 18, 2003Date of Patent: August 24, 2010Assignee: Medtronic, Inc.Inventor: Bruce D. Gunderson
-
Publication number: 20100204746Abstract: A system and method for passively testing a cardiac pacemaker in which sensing signal amplitudes and lead impedance values are measured and stored while the pacemaker is functioning in its programmed mode. The amplitude and impedance data may be gotten and stored periodically at regular intervals to generate a historical record for diagnostic purposes. Sensing signal amplitudes may also be measured and stored from a sensing channel which is currently not programmed to be active as long as the pacemaker is physically configured to support the sensing channel. Such data can be useful in evaluating whether a switch in the pacemaker's operating mode is desirable.Type: ApplicationFiled: April 22, 2010Publication date: August 12, 2010Inventors: Vickie L. Conley, James O. Gilkerson, David L. Perschbacher
-
Publication number: 20100204745Abstract: An apparatus comprises a primary cardiac signal sensing circuit to sense a first cardiac signal, a secondary cardiac signal sensing to sense a second cardiac signal, and an arrhythmia detection circuit. The primary sensing circuit includes at least first and second implantable electrodes, and the secondary sensing circuit includes a third implantable electrode to deliver high-energy shock therapy. The arrhythmia detection circuit detects tachyarrhythmia using the primary sensing circuit, determines correspondence between events sensed with the primary sensing circuit and events sensed with the secondary sensing circuit, and deems whether a detected rhythm is indicative of noise or is indicative of an arrhythmia according to the determined correspondence.Type: ApplicationFiled: January 26, 2010Publication date: August 12, 2010Inventors: Dan Li, David L. Perschbacher
-
Patent number: 7774063Abstract: A method and device for detecting cardiac signals in a medical device that includes decomposing sensed cardiac signals using a wavelet function to form a corresponding wavelet transform, generating a first wavelet representation corresponding to the wavelet transform that is responsive to RR intervals of the sensed cardiac signals, generating a second wavelet representation that is not responsive to RR intervals associated with the sensed cardiac signals, determining a no lead failure zone in response to the first wavelet representation and the second wavelet representation, and distinguishing the cardiac event from a device failure in response to the determined no lead failure zone.Type: GrantFiled: May 4, 2007Date of Patent: August 10, 2010Assignee: Medtronic, Inc.Inventors: Raja N. Ghanem, Troy E. Jackson
-
Patent number: 7774065Abstract: A system and method for measuring the capture threshold of a bipolar lead in order to determine an appropriate value for the stimulus pulse energy to be used with the lead by a cardiac rhythm management device. An appropriate bipolar stimulating configuration can also be determined. The method is particularly useful in testing bipolar leads used to excite the left ventricle such as when delivering cardiac resynchronization therapy.Type: GrantFiled: August 9, 2007Date of Patent: August 10, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Julio C. Spinelli, Qingsheng Zhu
-
Publication number: 20100198292Abstract: Described techniques include delivering cardiac pacing therapy from a medical device to a chamber of a heart via a first electrode configuration and determining that the delivery of cardiac pacing therapy via the first electrode configuration inadequately captures the chamber. In response to such a determination, the medical device delivers cardiac pacing therapy to the chamber of the heart via a plurality of additional electrode configurations. The techniques further comprise determining a capture characteristic for each of the additional electrode configurations based on the delivery of cardiac pacing therapy to the chamber of the heart via the plurality of other electrode configurations. A new electrode configuration for cardiac pacing may be selected based on the capture characteristics of the various electrode configurations.Type: ApplicationFiled: January 30, 2009Publication date: August 5, 2010Applicant: Medtronic, Inc.Inventors: Jordon D. Honeck, Robert T. Sawchuk
-
Patent number: 7769453Abstract: The present invention relates to an implantable battery-operated electrostimulation device (10), particularly for stimulating a heart, having a telemetry unit (11) for wireless data transmission between the electrostimulation device (10) and an external device (21), a control unit (15), which is connected to the telemetry unit (11) and is implemented to trigger a telemetric data transmission, a battery (13) for the power supply of the electrical components of the implant, such as the telemetry unit and the control unit, and a self-test unit, which is implemented to register the functional state of the electrostimulation device and independently detect acute or imminent malfunctions, the self-test unit (17) being connected to the control unit and the control unit being implemented to trigger a data transmission using data on the functional state of the electrostimulation device if an acute or imminent malfunction is detected.Type: GrantFiled: March 30, 2007Date of Patent: August 3, 2010Assignee: Biotronik CRM Patent AGInventors: Thomas Doerr, Torsten Lang
-
Patent number: 7761161Abstract: An implantable cardiac rhythm management system includes a user interface, such as an external programmer, for performing therapy energy threshold tests. The threshold tests allow the caregiver to determine the threshold energy at which paces capture the heart, i.e., cause a resulting contraction of the heart chamber to which the paces are delivered. The programmer provides recorded indications of the energy corresponding to each paced event, so that the caregiver can easily determine the point at which capture was lost. This recorded representation of pacing energy makes it easy for the caregiver to determine proper pacing thresholds to be used to ensure adequate pacing, while minimizing energy drain to prolong the useful life of the implanted device.Type: GrantFiled: June 29, 2006Date of Patent: July 20, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Vickie L. Conley, Allan T. Koshiol
-
Patent number: 7761156Abstract: In a method for operating an implantable heart stimulating device with atrial overdrive capability having an atrial stimulation unit for stimulating the atrium via stimulation electrode(s), an atrial evoked response detector determines an atrial evoked response amplitude, and an atrial control unit controls an atrial timing unit to set an atrial stimulation time interval length between consecutively applied atrial stimulation pulses. The atrial stimulation time interval length is set in dependent on the determined atrial evoked response amplitude such that the next time interval length is a predetermined percentage of the present time interval length. If the ER signal amplitude decreases, the stimulating interval has to be decreased. The control unit can also try to increase the stimulating interval back to back until a decrease in ER signal amplitude is seen in order to avoid too high stimulating rate.Type: GrantFiled: January 29, 2007Date of Patent: July 20, 2010Assignee: St. Jude Medical ABInventor: Anders Lindgren
-
Patent number: 7756580Abstract: Methods and systems for performing pacing interval optimization are provided. One or more optimum pacing interval is determined for each of a plurality of different ranges of heart rate, different levels of autonomic tone, different body temperature ranges, or combinations thereof. The information (e.g., measures of hemodynamic response) collected to perform pacing interval optimization can be collected and stored in a table over disjoint periods of time. Such measures of hemodynamic performance are preferably relative measures, but can alternatively be absolute measures.Type: GrantFiled: October 18, 2006Date of Patent: July 13, 2010Assignee: Pacesetter, Inc.Inventor: Robert G. Turcott
-
Publication number: 20100174337Abstract: A system and method recording sensing and pacing events in a cardiac rhythm management device. The method may be particularly useful in assessment of pacing parameters for ventricular resynchronization therapy.Type: ApplicationFiled: March 15, 2010Publication date: July 8, 2010Inventors: Jeffrey E. Stahmann, Rene H. Wentkowski, Andrew P. Kramer, James Kalgren
-
Patent number: 7751890Abstract: A self-diagnostic system for an implantable cardiac device such as a pacemaker, cardioverter, or resynchronization device which utilizes a subcutaneous ECG channel is described. The subcutaneous ECG channel allows the device to, in real time and independent of the standard pacing and sensing circuitry, verify the presence of pacing spikes, chamber senses, and other device outputs and hence establish and verify device integrity.Type: GrantFiled: July 14, 2004Date of Patent: July 6, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Aaron McCabe, David J. Yonce
-
Patent number: 7742823Abstract: A neural stimulation system automatically corrects or adjusts the stimulus magnitude (stimulation energy) in order to maintain a comfortable and effective stimulation therapy. Because the changes in impedance associated with the electrode-tissue interface can indicate obstruction of current flow and positional lead displacement, lead impedance can indicate the quantity of electrical stimulation energy that should be delivered to the target neural tissue to provide corrective adjustment. Hence, a change in impedance or morphology of an impedance curve may be used in a feedback loop to indicate that the stimulation energy needs to be adjusted and the system can effectively auto correct the magnitude of stimulation energy to maintain a desired therapeutic effect.Type: GrantFiled: May 10, 2007Date of Patent: June 22, 2010Assignee: Boston Scientific Neuromodulation CorporationInventors: John D. H. King, James R. Thacker
-
Publication number: 20100152805Abstract: A medical device includes a sensor for sensing for an MRI gradient magnetic field and a microprocessor for responding to the detected gradient magnetic field by switching from a first electrical signal processing mode to a second electrical signal processing mode, such that electrical signals induced by the gradient magnetic field and an associated RF burst are not counted as cardiac events.Type: ApplicationFiled: February 25, 2010Publication date: June 17, 2010Inventor: Volkert A. Zeijlemaker
-
Patent number: 7738958Abstract: Methods, apparatus and systems for enhancing cardiac pacing generally provide for measuring at least one cardiac characteristic, calculating at least one cardiac performance parameter based on the measured characteristic(s), and adjusting at least one functional parameter of a cardiac pacing device. Devices may include at least one catheter (such as a multiplexed catheter with one or more sensors and/or actuators), at least one implant (such as a sensor implantable in a heart wall), or a combination of both. Various cardiac performance parameters and/or pacing device performance parameters may be weighted, and the parameters and their respective weights may be used to determine one or more adjustments to be made to the pacing device. In some instances, the adjustments are made automatically.Type: GrantFiled: February 28, 2007Date of Patent: June 15, 2010Assignee: Proteus Biomedical, Inc.Inventors: Mark Zdeblick, Joseph M. Ruggio
-
Publication number: 20100137932Abstract: A cardiac rhythm management system modulates the delivery of pacing and/or autonomic neurostimulation pulses based on heart rate variability (HRV). An HRV parameter being a measure of the HRV is produced to indicate a patient's cardiac condition, based on which the delivery of pacing and/or autonomic neurostimulation pulses is started, stopped, adjusted, or optimized. In one embodiment, the HRV parameter is used to evaluate a plurality of parameter values for selecting an approximately optimal parameter value.Type: ApplicationFiled: February 3, 2010Publication date: June 3, 2010Inventors: Joseph M. Pastore, Rodney W. Salo, Gerrard M. Carlson, Andrew P. Kramer, Jiang Ding, Yinghong Yu
-
Patent number: 7729764Abstract: The efficacy of cardiac resynchronization therapy applied to a patient's heart by an implantable device are improved by obtaining acute hemodynamic feedback during implantation of a pacing device. A first and a second transducer are temporarily placed proximate to a portion of the patient's heart during device implant, and a distance between the transducers is monitored as the therapy is applied. A parameter (e.g. lead location, biventricular pacing, pacing rate, or the like) of the cardiac therapy is adjusted in response to the distance between the transducers until a desired result is obtained, after which the first and second transducers can be removed from the patient.Type: GrantFiled: March 31, 2005Date of Patent: June 1, 2010Assignee: Medtronic, Inc.Inventors: Douglas A. Hettrick, Paul D. Ziegler
-
Patent number: 7729765Abstract: A system and method for passively testing a cardiac pacemaker in which sensing signal amplitudes and lead impedance values are measured and stored while the pacemaker is functioning in its programmed mode. The amplitude and impedance data may be gotten and stored periodically at regular intervals to generate a historical record for diagnostic purposes. Sensing signal amplitudes may also be measured and stored from a sensing channel which is currently not programmed to be active as long as the pacemaker is physically configured to support the sensing channel. Such data can be useful in evaluating whether a switch in the pacemaker's operating mode is desirable.Type: GrantFiled: November 14, 2006Date of Patent: June 1, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Vickie L. Conley, James O. Gilkerson, David L. Perschbacher
-
Publication number: 20100131026Abstract: A cardiac rhythm management system modulates the delivery of pacing and/or autonomic neurostimulation pulses based on heart rate variability (HRV). An HRV parameter being a measure of the HRV is produced to indicate a patient's cardiac condition, based on which the delivery of pacing and/or autonomic neurostimulation pulses is started, stopped, adjusted, or optimized. In one embodiment, the HRV parameter is used as a safety check to stop an electrical therapy when it is believed to be potentially harmful to continue the therapy.Type: ApplicationFiled: January 26, 2010Publication date: May 27, 2010Inventors: Joseph M. Pastore, Rodney W. Salo, Gerrard M. Carlson, Andrew P. Kramer, Jiang Ding, Yinghong Yu
-
Publication number: 20100125308Abstract: An active implantable medical device including circuits for calculating an atrio ventricular delay (AVD) period. The device is able to detect the atrial and ventricular events; calculate an AVD and to start the AVD on detection of a spontaneous or paced atrial event. The device is able to deliver a low energy ventricular stimulation pulse at the expiration of the AVD in the absence of a detected spontaneous ventricular event. To calculate the AVD, the device uses an acceleration sensor to deliver an endocardiac acceleration (EA) signal representative of the movements produced by the contractions of the atrial cavity; and analyzes the EA signal to identify and isolate in the EA signal a component corresponding to the fourth peak of endocardiac acceleration (PEA4) associated to the atrial activity, and to calculate the AVD based on a parameter of this component.Type: ApplicationFiled: November 18, 2009Publication date: May 20, 2010Inventor: Cyrille CASSET
-
Publication number: 20100121403Abstract: An implantable cardiac therapy device and methods of using a device including an implantable stimulation pulse generator, one or more implantable leads defining sensing and stimulation circuits adapted to sense and deliver therapy in at least one right side heart chamber, and an implantable controller in communication with the stimulation pulse generator and the one or more patient leads so as to receive sensed signals indicative of a patient's physiologic activity and deliver indicated therapy. The controller is adapted to monitor at least one indicator of cardiac dysynchrony and to compare the at least one indicator to a determined dysynchrony threshold. The threshold is determined for indications that the patient be further evaluated for cardiac resynchronization therapy. The controller is further adapted to set an alert when the at least one indicator exceeds the threshold to indicate to a clinician that evaluation for bi-ventricular pacing might be indicated.Type: ApplicationFiled: November 7, 2008Publication date: May 13, 2010Applicant: PACESETTER, INC.Inventors: Stuart O. Schecter, Xiaoyi Min
-
Publication number: 20100114197Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Applicant: Medtronic, Inc.Inventors: John E. Burnes, Paul G. Krause, William T. Donofrio, Gerald P. Arne, David J. Peichel, Xiaohong Zhou, James D. Reinke, Timothy Davis
-
Publication number: 20100114201Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Xiaohong Zhou, Gerald P. Arne, David J. Peichel, James D. Reinke
-
Publication number: 20100114198Abstract: Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.Type: ApplicationFiled: January 30, 2009Publication date: May 6, 2010Inventors: William T. Donofrio, John E. Burnes, Paul G. Krause, Xiaohong Zhou, Gerald P. Arne, David J. Peichel, James D. Reinke
-
Publication number: 20100114221Abstract: An implantable medical system that includes a cardiac therapy module and a neurostimulation therapy module may identify when neurostimulation electrodes have migrated toward a patient's heart. In some examples, the system may determine whether the neurostimulation electrodes have migrated toward the patient's heart based on a physiological response to an electrical signal delivered to the patient via the neurostimulation electrodes. In addition, in some examples, the system may determine whether the neurostimulation electrodes have migrated toward the patient's heart based on an electrical cardiac signal sensed via the neurostimulation electrodes.Type: ApplicationFiled: October 30, 2009Publication date: May 6, 2010Applicant: Medtronic, Inc.Inventors: Paul G. Krause, Avram Scheiner
-
Patent number: 7711424Abstract: Cardiac devices and methods involve the detection of cardiac signals features in adjacent classification intervals. Portions of the cardiac signal features detected in adjacent classification intervals are associated and are used to classify the cardiac response to a pacing pulse. Associating the portions of the cardiac signal features may be based on expected signal morphology.Type: GrantFiled: February 14, 2008Date of Patent: May 4, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Scott A. Meyer, Yanting Dong, Kevin John Stalsberg
-
Patent number: 7706882Abstract: A method of thermal ablation using high intensity focused ultrasound energy includes the steps of positioning one or more ultrasound emitting members within a patient, emitting ultrasound energy from the one or more ultrasound emitting members, focusing the ultrasound energy, ablating with the focused ultrasound energy to form an ablated tissue area and removing the ultrasound emitting member.Type: GrantFiled: May 13, 2005Date of Patent: April 27, 2010Assignee: Medtronic, Inc.Inventors: David E. Francischelli, James B. Hissong, James R. Keogh, James R. Skarda, Mark T. Stewart
-
Patent number: 7706883Abstract: Techniques for communicating with implantable medical devices (IMDs) in a manner that promotes efficient data retrieval are described. The techniques involve ways to streamline retrieval of data stored on a patient's IMD. In one exemplary technique, first and second data ranges are determined for retrieval from an IMD. The technique evaluates whether the first data range overlaps or is separated by less than a predefined amount from the second data range. In an event where the first and second data ranges overlap or are separated by less than the predefined amount, the technique requests a third data range from the IMD which encompasses the first and second data ranges.Type: GrantFiled: April 6, 2006Date of Patent: April 27, 2010Assignee: Pacesetter, Inc.Inventor: Tejpal Singh
-
Publication number: 20100100148Abstract: An exemplary method includes performing a ventricular capture assessment, determining a ventricular paced propagation delay (PPD) and/or an interventricular conduction delay (IVCD) using information acquired during the ventricular capture assessment and optimizing at least an interventricular delay (VV) based at least in part on the ventricular paced propagation delay (PPD) and/or the interventricular conduction delay (IVCD). Another exemplary method includes performing an atrial capture assessment, determining an atrial evoked response width (?A) and one or more atrio-ventricular intervals (AR) using information acquired during the atrial capture assessment and optimizing an atrio-ventricular (PV or AV) delay based at least in part on the atrial evoked response width (?A) and the one or more atrio-ventricular intervals (AR). Other exemplary methods, devices, systems, etc., are also disclosed.Type: ApplicationFiled: October 21, 2008Publication date: April 22, 2010Applicant: PACESETTER, INC.Inventors: Xiaoyi Min, Jeffery D. Snell
-
Patent number: 7702392Abstract: Methods and apparatus for determining an endocardial implantation site for implanting an electrode, such as a leadless stimulation electrode. An embodiment of one method in accordance with the invention includes delivering sufficient electrical energy for initiation of cardiac activation to a plurality of different test locations at the heart of a patient, and determining hemodynamic responses in reaction to that the stimulus delivered to the different test locations. This method further includes identifying an implantation site for implanting the electrode by selecting at least one of the test locations corresponding to a favorable hemodynamic response.Type: GrantFiled: February 10, 2006Date of Patent: April 20, 2010Assignee: EBR Systems, Inc.Inventors: Debra S. Echt, Richard E. Riley, Mark W. Cowan, Axel F. Brisken
-
Patent number: 7697985Abstract: An implantable medical device (IMD) identifies lead performance issues and provides alternative lead configurations to continue with the programmed therapy. In the absence of an appropriate alternatively lead configuration, the IMD determines alternative mechanisms to provide a similar therapy or to determine a secondary therapy.Type: GrantFiled: July 26, 2005Date of Patent: April 13, 2010Assignee: Medtronic, Inc.Inventors: Daniel R. Kaiser, John E. Burnes, Thomas J. Mullen
-
Publication number: 20100087891Abstract: A method for diagnosing an implantable cardiac device including a plurality of implanted leads may include: monitoring a plurality of parameters associated with the plurality of implanted leads; detecting a change in one of the parameters; evaluating at least one of the other parameters upon detection of the change; and diagnosing a problem with the implantable cardiac device based on the detected change and the evaluation. A system for diagnosing an implantable cardiac device including a plurality of implanted leads may include an implantable pacing device and a processor. The processor may be configured to: monitor a plurality of parameters associated with the plurality of implanted leads; detect a change in one of the parameters; evaluating at least one of the other parameters upon detection of the change; and diagnose a problem with the implantable cardiac device based on the detected change and the evaluation.Type: ApplicationFiled: October 8, 2008Publication date: April 8, 2010Applicant: PACESETTER, INC.Inventors: Paul A. Levine, Hanbiao Wang, Bonian Dai, Robert E. Smith, JR.
-
Publication number: 20100087890Abstract: A system, method, or device monitor a force-frequency relationship exhibited by a patient's heart. A contractility characteristic, such as a heart sound characteristic of an S1 heart sound, is measured. The contractility characteristic indicates the forcefulness of a contraction of the heart. The frequency at which the heart is contracting is determined. A group of (contractility characteristic, heart rate) pairs is stored in a memory device. The group of pairs defines a force-frequency relationship for the heart. The method may be implemented by an implantable device, or by a system including a implantable device.Type: ApplicationFiled: December 9, 2009Publication date: April 8, 2010Inventors: RAMESH WARIAR, GERRARD M. CARLSON
-
Patent number: 7693575Abstract: A heart stimulator for electrical stimulation of a heart chamber includes a sensing stage sensing excitation of the heart chamber via an electrode lead having an electrode for picking up heart chamber electric potentials, a stimulation pulse generator generating electric stimulation pulses for delivery to the heart chamber via a stimulation electrode, and a control unit connected to the sensing stage and the stimulation pulse generator and being adapted to trigger the stimulation pulses at a controlled stimulation rate. A monitoring stage is provided for preventing too high of a stimulation rate for too long of a period of time, with the monitoring stage being connected to the control unit and being adapted to monitor the controlled stimulation rate, and to override the controlled stimulation rate by a fixed stimulation rate for a predetermined period of time if the average controlled stimulation rate exceeds a predetermined maximum rate.Type: GrantFiled: November 27, 2006Date of Patent: April 6, 2010Assignee: Biotronik CRM Patent AGInventors: Dirk Muessig, Kurt Swenson
-
Publication number: 20100076512Abstract: A cardiac interface device helps program an implantable cardiac rhythm or function management device, such as to reduce unnecessary ventricular pacing to avoid contributing to the advancement of heart failure disease progression. An intrinsic conducted AV interval is measured for at least one heart rate, and is predicted or measured for other heart rates. One or more of an age-predicted upper rate limit, a measured sensed AV offset, a PVARP based on measured retrograde conduction time can be used to determine an AV search hysteresis control parameter, and a resulting ventricular interval is graphically displayed relative to the intrinsic conducted AV interval at various heart rates. Confidence intervals or percentage ventricular pacing can also be displayed. Separate graphs for sense and pace initiated AV intervals can be provided.Type: ApplicationFiled: November 24, 2009Publication date: March 25, 2010Inventor: Michael P. Husby
-
Publication number: 20100076515Abstract: Methods for performing cardiac signal analysis in an implanted medical device, and devices configured to perform illustrative methods of cardiac signal analysis. A cardiac signal is captured by an implanted device using implanted electrodes and, during at least certain conditions, the cardiac signal undergoes heuristic filtering. In some embodiments, heuristic filtering is achieved by modifying a signal or value that is used as an indicator of received signal amplitude. In an illustrative example, the heuristic filtering includes periodically incrementing or decrementing the signal or value toward a desired quiescent point, where the heuristic filter period is significantly longer than the sampling period for the signal itself. In another illustrative example, the heuristic filter frequency can be adjusted dynamically to keep the signal average near the desired quiescent point.Type: ApplicationFiled: November 24, 2009Publication date: March 25, 2010Inventor: James William Phillips
-
Publication number: 20100063561Abstract: A plurality of electrodes are implanted in, on or near the patient's heart and initially configured to define first circuits or vectors enabled for at least one of sensing and stimulating and second circuits or vectors which are idle for at least one of sensing and stimulating. Selected first circuits or second circuits are tested for fault indications related to one or both of sensing and stimulating and a status record is updated to indicate corresponding sensing fault indications and stimulating fault indications. If a sensing fault is found in one of the first circuits, the first circuit is redefined when enabled for sensing to include at least one electrode of a second circuit that does not have a record of a sensing fault indication. Likewise, if a stimulating fault is found in one of the first circuits, the first circuit is redefined when enabled for stimulating to include at least one electrode of a second circuit that does not have a record of a stimulating fault indication.Type: ApplicationFiled: September 5, 2008Publication date: March 11, 2010Applicant: PACESETTER, INC.Inventors: Laurence S. Sloman, Jeffery D. Snell
-
Patent number: 7676267Abstract: A method and system for verifying capture in the heart involves the use of pacing artifact templates. One or more pacing artifact templates characterizing a post pace artifact signal associated with a particular pace voltage or range of voltages are provided. A pacing artifact template is canceled from a cardiac signal sensed following a pacing pulse. Capture is detected by comparing the pacing artifact canceled cardiac signal to an evoked response reference. Fusion/pseudofusion detection involves determining a correlation between a captured response template and a sensed cardiac signal.Type: GrantFiled: March 13, 2007Date of Patent: March 9, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Jaeho Kim, Joseph Bocek
-
Publication number: 20100057155Abstract: Embodiments of the present invention relate to monitoring a patient's atrial stretch, heart failure (HF) condition, and/or risk of atrial fibrillation (AF), as well as methods for estimating a change in at least one of a patient's left atrial pressure (LAP), pulmonary capillary wedge pressure (PCWP), and right pulmonary artery pressure (RPAP). Embodiments of the present invention also relate to selecting a pacing energy level. Such embodiments involve determining atrial evoked response metrics when a patient's atrium is paced, and monitoring changes in such metrics.Type: ApplicationFiled: September 4, 2008Publication date: March 4, 2010Applicant: PACESETTER INC.Inventors: Taraneh Ghaffari Farazi, Fujian Qu
-
Patent number: 7670363Abstract: A method and apparatus for protecting an electronic implantable medical device prior to it being implanted in a patient's body. The apparatus affords protection against electronic component damage due to electrostatic discharge and/or physical damage due to improper handling. The apparatus is comprised of a circuit board having conductive surface means for receiving and releasably grasping the electrodes of the medical device to support the device's housing proximate to the surface of the circuit board. First and second conductive paths are formed on the circuit board extending between the first and second conductive surfaces for shunting electrostatic discharge currents to prevent such currents from passing through the device's electronic circuitry. The respective shunt paths include oppositely oriented diodes, preferably comprising diodes which emit light (i.e., LEDs) when current passes therethrough. Additionally, means are provided to enable functional testing of the medical device.Type: GrantFiled: September 8, 2006Date of Patent: March 2, 2010Assignee: Alfred E. Mann Foundation for Scientific ResearchInventors: Martin J. Vogel, Adam Vogel, legal representative, Richard J. Nelson, Robert A. Firth, Anthony D. Falco, Joseph H. Schulman, Lung-Hsi Chu, Lee J. Mandell
-
Patent number: 7672732Abstract: An apparatus for powering an implant includes first energy interface elements, a removeably attachable holding device and a first energy source, such as a battery. An energy conversion circuit converts first energy into second energy which is transmitted within the body of the patient to the implant. Also, an apparatus for providing information to an implant that includes first energy interface elements and a housing that includes a processor operatively coupled to the first energy interface elements and an energy source operatively coupled to the processor. The processor is structured to generate an information signal and cause the signal to be transmitted within the body of the patient for delivery to the implant. Associated methods are also provided.Type: GrantFiled: March 29, 2007Date of Patent: March 2, 2010Assignee: University of Pittsburgh - Of the Commonwealth System of Higher EducationInventors: Mingui Sun, Robert J. Sclabassi, Daliang L. Li, Jun Zhao, Steven Hackworth